Summary of Huace Testing Conference Call Company Overview - **Company**: Huace Testing - **Industry**: Testing and Inspection Services Key Points Financial Performance - In Q2 2025, Huace Testing achieved a significant single-digit growth in revenue despite a high base effect from the previous year, with net profit growth between 7% and 9.6% compared to market expectations of 0% to 5% [2][3] - The company’s revenue for the food segment is expected to grow by 10% to 15%, driven by new product lines in pet food and agricultural products, as well as increased domestic food safety concerns [2][4] - The medical and pharmaceutical segment showed slight growth, entering a phase of reduced losses, with a recovery in CRO orders and accelerated development of new medical device businesses [2][5] - The environmental segment faced revenue pressure due to a high base from the previous year but is expected to recover in the second half of the year [2][5] - The consumer products segment, particularly automotive testing, exceeded expectations, and chip testing is anticipated to improve after previous profit drag [2][5] Segment Performance - **Food Segment**: Expected to maintain high growth due to increased food safety awareness and contributions from the South African acquisition [2][4] - **Medical and Pharmaceutical Segment**: Anticipated to achieve double-digit growth in the second half of 2025, benefiting from reduced base pressure and positive developments in other businesses [2][4][6] - **Environmental Segment**: Revenue is expected to recover as base pressure eases [2][6] - **Consumer Products and Industrial Segment**: Continuous recovery and accelerated development are expected, with ship oil testing projected to grow by 20% to 30% due to new regulations [2][5] Profitability and Cash Flow - The overall profit level showed significant recovery in Q2 2025, with improved gross margins and good cash flow performance, expecting to recover approximately 10 million yuan [2][7] - The company is transitioning from a state of no cash recovery in the previous year to normal cash recovery in the current year [2][7] Future Outlook - For the second half of 2025, Huace Testing is expected to continue its recovery and accelerate growth across all major business segments [2][6] - The company aims for a minimum performance of 1.02 billion yuan, with potential to exceed 1.05 billion yuan [2][8] - The past three years of valuation adjustments were influenced by economic downturns, unmet internationalization expectations, and foreign capital withdrawal, but improvements are now evident [2][9][10] - The company is positioned for a turning point in performance and cash flow, with a projected growth rate of 15% to 20% as it expands into international markets [2][11] Strategic Initiatives - Huace Testing is focusing on international expansion, particularly in South Africa, Southeast Asia, and Europe, with an emphasis on acquisitions in consumer, food, ESG, and transportation sectors [2][4][8][11] - The company is expected to benefit from a more favorable foreign capital structure and improved market conditions [2][9][11]

联合研究丨行业点评 [Table_Title] "反内卷"政策下，检测服务公司盈利性走势如 何？ %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 请阅读最后评级说明和重要声明 2 / 10 %% %% %% %% research.95579.com 2 [Table_Title "反内卷"政策下，检测服务公司盈利性走势如 2] 何？ [Table_Summary] 检测服务从高速增长阶段过渡到中低增速的稳健增长阶段；2024 年我国检测检验市场规模达 到约 4876 亿元，同比仅增长 4.4%；机构数量 53057 家，同比减少 1.4%，为历年来首次出现 机构数量下降。"反内卷"政策下，检测机构的毛利率有望趋稳。当前时点，重点推荐两条线索： 1）内部经营拐点明确的综合性检测机构；2）重点布局需求复苏方向明确板块的优质龙头。 分析师及联系人 [Table_Author] 徐科 赵智勇 贾少波 SAC：S0490517090001 SAC：S0490517110001 SAC：S0490520070003 SFC：BUV415 SFC：BRP550 曹小敏 SAC ...